ISRCTN - ISRCTN97125464: The SCOPE 2 Trial: Study of chemoradiotherapy in oesophageal cancer including PET response and dose escalation
0
The SCOPE 2 Trial: Study of chemoradiotherapy in oesophageal cancer including PET response and dose escalation
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario